Market Place
Sourcing Support
Latigo Bio Closes $150M Series B to Advance Pain Therapeutics
17 Mar 2025 //
PR NEWSWIRE
Latigo Bio Granted FDA Fast Track Designation for LTG-001
03 Mar 2025 //
PR NEWSWIRE
Latigo Biotherapeutics Appoints Timothy P. Walbert as Board Chair
19 Nov 2024 //
PR NEWSWIRE
Pain medicine biotech Latigo taps CRO founder for CMO role
20 Aug 2024 //
FIERCE BIOTECH
Latigo Bio Reports Positive Phase 1 Data, Appoints New Chief Medical Officer
19 Aug 2024 //
PR NEWSWIRE
Latigo Biotherapeutics Names New CEO
22 Jul 2024 //
CONTRACT PHARMA
Latigo Biotherapeutics Debuts with $135 Million Series A Financing
14 Feb 2024 //
PR NEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.